IFNG and cancer: The immune response of T cells to K562 and K562/A24 cells treated with Eps8-derived peptides 327, 534, 334 or 755 (10 μM) was assessed by interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISPOT) assays after we isolated peripheral blood mononuclear cells (PBMCs) from five healthy individuals as well as four patients with cancer (Supplementary Tables 1 and 2).